title: Editorial Comment from Dr Kitta to effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model.
authors.forename: Takeya
authors.initials: T
authors.lastname: Kitta
mesh_terms: D000818:Animals; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D002208:Caproates / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000494:pharmacology; D003556:Cystitis / Q000139:chemically induced / Q000188:drug therapy*; D004195:Disease Models, Animal; D005260:Female; D007278:Injections, Spinal; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D058306:Receptors, Prostaglandin E, EP1 Subtype / Q000037:antagonists & inhibitors*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014554:Urination / Q000187:drug effects
chemical_list: D001643:Bridged Bicyclo Compounds; D002208:Caproates; C122148:ONO 8711; D058306:Receptors, Prostaglandin E, EP1 Subtype; D003520:Cyclophosphamide